Oramed COO Executes Strategic Sell‑Buy Trade, Signals Confidence Amid Market Rally
Oramed insider Hexter Joshua trades 137k shares then buys 50k—showing strategic rebalancing and confidence in the company’s oral‑delivery platform.
3 minutes to read
ORAMED PHARMACEUTICALS INC
Oramed CEO Secures 167k RSUs Amid Executive Buying Surge—Signals Bullish Outlook for Oral Insulin Launch
Oramed insiders boost confidence: CEO Nadav’s RSU award and executive buying signal strong alignment with upcoming oral insulin launch, hinting at future upside.
4 minutes to read
Oramed Executives Flip the Switch: CFO Avraham’s First RSU Grant Signals Bullish Future, Amid Mixed Insider Trades and Rising Stock Price
Oramed’s new RSU grants signal management’s confidence, boosting investor optimism about its oral‑insulin platform’s future upside.
3 minutes to read